Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
BENZAL 25% LOTION 100ML
- Sku : I-000647
Key features
BENZAL 25% Lotion is a topical preparation containing benzyl benzoate 25% as its active ingredient. It acts as an ectoparasiticide with neurotoxic effects on mites and lice, causing paralysis and death; ovicidal activity is limited/variable. It is indicated for the topical treatment of scabies and pediculosis (lice infestation). Available OTC in a 100 ml lotion pack.- Brand: BENZAL
- Active Ingredient: BENZYL BENZOATE 25%
- Strength: 25%
- Dosage Form: Lotion
- Pack Size: 100 ml
- Route: Topical
- Prescription Status: OTC
- Therapeutic Class: Antiparasitic
- Pharmacological Group: Ectoparasiticides
- Drug Class: Topical ectoparasiticide: scabicide and pediculicide (benzyl benzoate; ATC P03AX01).
- Manufacturer: Dallah Pharma Factory
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 2207257799
- Shelf Life: 36 months
- Storage: do not store above 30°c
- Skin Condition: Parasitic (Scabies, Lice)
Frequently bought together
Indications
Approved Uses
Scabies and pediculosis (lice infestation).
Dosage & Administration
Dosing by Condition
Apply 25% lotion to the entire body (neck down; include folds and under nails); for children <2 years or elderly include scalp/face avoiding eyes/mouth. Leave on 24 hours (or 3 days daily in some protocols) then wash off; repeat after 1 week if needed. Treat contacts and decontaminate fomites.
Initial Dose
Apply a thin layer to the entire body surface from neck downward (for scabies) or to affected area (for lice)
Maintenance Dose
A second application may be repeated after 24 hours or within 5-7 days.
Maximum Dose
Typical maximum is 2 full-body applications per treatment course (often 24 hours apart, then wash off), with a repeat course after 7 days if needed; do not exceed without clinician direction.
Children's Dosage
Children 2-12 years: Dilute 1:1 with water to obtain 12.5% concentration before application; not recommended under 2 years of age
Dose Adjustment Notes
Children and patients with sensitive skin may require dilution (commonly to 12.5% by mixing 1:1 with water) to reduce irritation; avoid use in very young infants unless specifically directed, and use caution on inflamed/broken skin.
How to Take
Shake well. Apply to clean, dry skin. For scabies: apply to the whole body from the neck down (include skin folds, between fingers/toes, under nails); in infants/young children and elderly, also apply to scalp/face avoiding eyes and mouth. Leave on for 24 hours then wash off thoroughly; reapply to hands if washed during the contact period. Avoid eyes, mucous membranes, and broken/irritated skin; wash hands after application (or wear gloves when applying to others).
How to Prepare
Dilution may be required for children depending on age/local labeling (commonly dilution to ~12.5% for younger children); follow the product leaflet/local guideline for age-specific dilution and application.
Side Effects
Common Side Effects
Local skin irritation (burning/stinging), erythema/redness, pruritus (may persist transiently after treatment), and contact dermatitis.
Side Effect Frequency
Most common: local skin irritation (burning/stinging, erythema, pruritus); allergic/contact dermatitis is uncommon/rare; systemic toxicity is rare and mainly associated with excessive use or application to broken skin/large areas.
Safety & Warnings
Contraindications
Hypersensitivity to benzyl benzoate or any excipient; avoid application to broken/very inflamed skin and avoid eyes/mucous membranes; avoid use in infants <2 years (commonly treated as a contraindication/strong precaution depending on local labeling).
Warnings & Precautions
Avoid eyes/mucous membranes; do not apply to broken, raw, or severely inflamed skin; may cause transient burning/itching; avoid excessive or repeated applications (risk of irritation/systemic absorption); wash hands after use and prevent transfer to face/eyes; treat close contacts and decontaminate clothing/bedding when used for scabies; keep away from heat/flame if product is alcohol-based/flammable per labeling.
Age Restriction
Avoid in infants <2 years; use with caution in children ≥2 years (often diluted and/or shorter contact time per local guidance).
Driving Warning
Safe
Drug Interactions
Drug Interactions
No clinically significant systemic drug interactions expected; avoid or use caution with concurrent topical irritants/keratolytics or other scabicides on the same area due to additive irritation.
Interaction Severity
MINOR: Concurrent use of other topical irritants/keratolytics or harsh soaps may increase local irritation; avoid layering multiple scabicides unless directed.
Food Interaction
None (not applicable for topical use).
Alcohol Interaction
Safe
Special Populations
Pregnancy
Caution
Breastfeeding
Caution
Children
Children 2-12 years: Dilute 1:1 with water to obtain 12.5% concentration before application; not recommended under 2 years of age
Kidney Impairment
No adjustment needed
Liver Impairment
No adjustment needed.
Storage & Patient Advice
Preparation Instructions
Dilution may be required for children depending on age/local labeling (commonly dilution to ~12.5% for younger children); follow the product leaflet/local guideline for age-specific dilution and application.
Stopping the Medicine
Safe to stop at any time, but for scabies treatment complete the recommended regimen; do not continue repeated applications beyond the regimen without medical advice.
Overdose
Topical overuse: marked burning/irritation/contact dermatitis; ingestion: GI upset and CNS toxicity (agitation, tremor, seizures). Management: remove from skin by washing; if ingested seek urgent medical care/poison center-supportive care (do not induce vomiting; decontamination per toxicology advice).
Patient Counseling
Apply to clean, dry skin for scabies to the whole body from neck down (include finger/toe webs, under nails, genital/buttock folds; include scalp/face only if advised for infants/elderly/immunocompromised); avoid eyes/mucosa and broken skin; leave on per local protocol (commonly 24 hours) then wash off; treat all close contacts simultaneously; decontaminate clothing/linen (hot wash/dry or isolate); itching may persist 2-4 weeks after cure; consider repeat application in 7 days if recommended locally.
Monitoring Requirements
No routine laboratory monitoring; reassess clinically for treatment failure or reinfestation if symptoms persist (itch can last 2-4 weeks after successful scabies treatment).
Pharmacology
Mechanism of Action
Ectoparasiticide with neurotoxic effects on mites/lice leading to paralysis and death; ovicidal activity is limited/variable, so repeat treatment may be needed.
Onset of Action
Mite-killing effect begins within hours after adequate skin contact; symptomatic improvement in itching/rash may take several days and post-scabetic pruritus can persist for 2-4 weeks despite eradication.
Duration of Effect
Mite-killing effect persists during the period the lotion remains on the skin (typically 8-24 hours per application); there is minimal residual activity after washing off.
Half-Life
Not well defined for topical benzyl benzoate; systemic half-life is not clinically meaningful because systemic exposure is usually minimal with correct use.
Bioavailability
Low systemic bioavailability with intact skin; some percutaneous absorption can occur and increases with damaged skin/large surface area/occlusion.
Metabolism
Hydrolyzed to benzyl alcohol and benzoic acid; benzyl alcohol is oxidized to benzoic acid; benzoic acid is conjugated with glycine to hippuric acid.
Product Information
Available Dosage Forms
Lotion (this product: BENZAL 25% LOTION).
Composition per Dose
Each 100 ml lotion: 25 g benzyl benzoate (25% w/v)
Generic Availability
Yes
OTC Alternatives
Permethrin 5% cream (where available OTC) and sulfur 5-10% topical preparations are common alternatives; malathion 0.5% lotion may be an alternative in some formularies/regions.
Skin Condition
Parasitic (Scabies, Lice)
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)














